We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Occurrence of pharmaceuticals in Latin America: case study on hazard assessment and prioritization in Costa Rica.
- Authors
Rodríguez-Rodríguez, Carlos E.; Ramírez-Morales, Didier; Gutiérrez-Quirós, Juan Antonio; Rodríguez-Saravia, Sebastián; Villegas-Solano, Diego
- Abstract
Pharmaceuticals are considered as contaminants of emerging concern, and their occurrence in diverse environmental matrices has been described during the last 25 years. Nonetheless, pharmaceutical occurrence has not been evenly described worldwide, and reports from some geographical areas such as most parts of Latin America are scarce. This work aims to address the situation of water pollution due to pharmaceuticals in Latin America by means of two main goals: i. First, reviewing the monitoring studies performed in Latin America on this topic (period 2009—2024), which were conducted in Brazil, Mexico, Colombia, Ecuador, Peru and Argentina, to highlight the most frequently detected compounds from each therapeutic group in the region. ii. Second, analyzing the case of Costa Rica through the hazard assessment and prioritization of pharmaceuticals based on the monitoring performed in this country (years 2011; 2018—2019). The monitoring in Costa Rica comprised a total of 163 sampling points: wastewater treatment plants (WWTPs) (14 urban WWTPs plus two landfill WWTPs; total samples n = 44 influents and n = 34 effluents), nine hospital effluents (n = 32), wastewater from livestock farms (six swine farms and seven dairy farms; n = 23 influents and n = 37 effluents), 64 continental surface water sampling points (n = 137), and 61 coastal seawater sampling points (n = 61). Risk assessment of detected concentrations by the hazard quotient (HQ) approach (period 2018–2019) revealed a total of 25 medium or high-hazard compounds (out of 37 detected compounds). The prioritization approach (which included the Frequency of Appearance (FoA), the Frequency of PNEC exceedance (FoE), and the Extent of predicted no-effect concentration (PNEC) exceedance (EoE)), showed a critical list of nine pharmaceuticals: caffeine, diphenhydramine, acetaminophen, lovastatin, gemfibrozil, ciprofloxacin, ibuprofen, doxycycline and norfloxacin. These compounds should be taken into account as a first concern during the implementation of environmental policies related to pharmaceutical products in the region.
- Subjects
EMERGING contaminants; POLLUTION risk assessment; SWINE farms; SEWAGE disposal plants; DAIRY farms; TRICLOCARBAN; CAFFEINE
- Publication
Environmental Monitoring & Assessment, 2024, Vol 196, Issue 8, p1
- ISSN
0167-6369
- Publication type
Article
- DOI
10.1007/s10661-024-12872-z